| Literature DB >> 26946499 |
Adrien E Groot1, Ivo N van Schaik1, Marieke C Visser2, Paul J Nederkoorn1, Martien Limburg3, Majid Aramideh4, Frank de Beer5, Caspar P Zwetsloot6, Patricia Halkes4, Jelle de Kruijk7, Nyika D Kruyt8,9, Willem van der Meulen10, Fianne Spaander8, Taco van der Ree11, Vincent I H Kwa12, Renske M Van den Berg-Vos13, Yvo B Roos1, Jonathan M Coutinho14.
Abstract
Centralization of intravenous thrombolysis (IVT) for acute ischemic stroke in high-volume centers is believed to improve the door-to-needle times (DNT), but limited data support this assumption. We examined the association between DNT and IVT volume in a large Dutch province. We identified consecutive patients treated with IVT between January 2009 and 2013. Based on annualized IVT volume, hospitals were categorized as low-volume (≤ 24), medium-volume (25-49) or high-volume (≥ 50). In logistic regression analysis, low-volume hospitals were used as reference category. Of 17,332 stroke patients from 11 participating hospitals, 1962 received IVT (11.3 %). We excluded 140 patients because of unknown DNT (n = 86) or in-hospital stroke (n = 54). There were two low-volume (total 101 patients), five medium-volume (747 patients) and four high-volume hospitals (974 patients). Median DNT was shorter in high-volume hospitals (30 min) than in medium-volume (42 min, p < 0.001) and low-volume hospitals (38 min, p < 0.001). Patients admitted to high-volume hospitals had a higher chance of DNT < 30 min (adjusted OR 3.13, 95 % CI 1.70-5.75), lower risk of symptomatic intracerebral hemorrhage (adjusted OR 0.39, 95 % CI 0.16-0.92), and a lower mortality risk (adjusted OR 0.45, 95 % CI 0.21-1.01), compared to low-volume centers. There was no difference in DNT between low- and medium-volume hospitals. Onset-to-needle times (ONT) did not differ between the groups. Hospitals in this Dutch province generally achieved short DNTs. Despite this overall good performance, higher IVT volumes were associated with shorter DNTs and lower complication risks. The ONT was not associated with IVT volume.Entities:
Keywords: Door-to-needle time; High-volume; Hospitals; Stroke; Thrombolytic therapy
Mesh:
Substances:
Year: 2016 PMID: 26946499 PMCID: PMC4826653 DOI: 10.1007/s00415-016-8076-5
Source DB: PubMed Journal: J Neurol ISSN: 0340-5354 Impact factor: 4.849
Baseline characteristics
| Annualized IVT volumea |
|
|
| |||
|---|---|---|---|---|---|---|
| 0–24 | 25–49 | ≥50 | ||||
| No. of hospitals (no. of patients) | 2 (101) | 5 (747) | 4 (974) | – | – | – |
| Male sex | 55.4 % | 55.7 % | 53.6 % | 0.963 | 0.722 | 0.387 |
| Mean age—year (±SD) | 68.6 ± 14.1 | 70.0 ± 14.1 | 70.0 ± 14.6 | 0.442 | 0.358 | 0.636 |
| Mean systolic blood pressure—mmHg (±SD) | 156.4 ± 26.7 | 155.9 ± 24.6 | 154.8 ± 24.5 | 0.819 | 0.862 | 0.267 |
| Mean diastolic blood pressure—mmHg (±SD) | 85.3 ± 13.9 | 86.7 ± 15.6 | 83.5 ± 16.3 | 0.611 | 0.223 | <0.001 |
| Median NIHSS (IQR) | 9 (5–11) | 8 (5–13) | 7 (4–12) | 0.478 | 0.698 | 0.027 |
| Risk factors | ||||||
| Atrial fibrillation | 15.1 % | 12.2 % | 10.8 % | 0.433 | 0.209 | 0.355 |
| Diabetes | 14.0 % | 16.6 % | 17.0 % | 0.515 | 0.462 | 0.853 |
| Hypertension | 32.3 % | 42.4 % | 46.0 % | 0.062 | 0.011 | 0.137 |
| Smoking (former or current) | 48.9 % | 47.8 % | 48.8 % | 0.878 | 0.984 | 0.723 |
| Prior stroke or TIA | 33.3 % | 26.4 % | 29.3 % | 0.157 | 0.410 | 0.194 |
| Stroke mimic | 1.0 % | 1.1 % | 0.3 % | 0.941 | 0.284 | 0.049 |
aCategorization of hospitals is based on the total number of IVT procedures in a particular hospital during the study period (4 years), divided by four. For instance, low-volume hospitals on average performed less than 25 IVT procedures per year (100 in total). Due to annual variation it is possible that in a single year, a low-volume hospital performed more than 25 IVT procedures
Outcomes
| Annualized IVT volume |
|
|
| |||
|---|---|---|---|---|---|---|
| 0–24 | 25–49 | ≥50 | ||||
| Proportion treated with IVT | 3.8 % | 11.3 % | 12.1 % | <0.001 | <0.001 | 0.02 |
| DNTa | 38 (29–59) | 42 (32–58) | 30 (22–45) | 0.139 | <0.001 | <0.001 |
| ONTa | 103 (69–161) | 120 (90–167) | 115 (82–170) | 0.002 | 0.035 | 0.030 |
| ODTa | 55 (32–99) | 65 (45–105) | 75 (48–120) | 0.008 | <0.001 | 0.001 |
| Door-to-CTa | 18 (11–28) | 20 (13–29) | 12 (7–18) | 0.314 | <0.001 | <0.001 |
| DNT < 60 min | 74.3 % | 76.7 % | 84.1 % | 0.586 | 0.012 | <0.001 |
| DNT < 45 min | 61.4 % | 52.6 % | 71.9 % | 0.097 | 0.027 | <0.001 |
| DNT < 30 min | 26.7 % | 17.4 % | 43.8 % | 0.023 | 0.001 | <0.001 |
| Complications | ||||||
| In-hospital mortality | 16.8 % | 8.0 % | 8.9 % | 0.004 | 0.011 | 0.504 |
| Any ICH | 13.9 % | 7.0 % | 5.0 % | 0.016 | <0.001 | 0.077 |
| Symptomatic ICH | 9.9 % | 5.8 % | 4.3 % | 0.108 | 0.013 | 0.168 |
| Pneumonia | 11.9 % | 8.3 % | 7.9 % | 0.251 | 0.164 | 0.680 |
| Urinary tract infection | 4.0 % | 7.4 % | 6.3 % | 0.207 | 0.357 | 0.362 |
| ICU admission | 5.0 % | 3.1 % | 3.8 % | 0.323 | 0.570 | 0.420 |
| Hemicraniectomy | 1.0 % | 2.1 % | 2.2 % | 0.438 | 0.431 | 0.984 |
| Epileptic seizure | 3.0 % | 1.7 % | 3.4 % | 0.394 | 0.824 | 0.036 |
IVT intravenous thrombolysis, DNT door-to-needle time, ONT onset-to-needle time, ODT onset-to-door time, ICH intracerebral hemorrhage, IQR interquartile range, ICU intensive care unit
aGiven as median minutes with IQR between parentheses
Multivariate analyses
| Unadjusted OR (95 % CI) | Adjusted OR (95 % CI) | ||
|---|---|---|---|
| DNT < 30 min | |||
| Low-volume | 27/101 (27 %) | 1.0a | 1.0a |
| Medium-volume | 130/747 (17 %) | 0.58 (0.36–0.93) | 0.83 (0.45–1.55) |
| High-volume | 427/974 (44 %) | 2.14 (1.35–3.38) | 3.13 (1.70–5.75) |
| DNT < 45 min | |||
| Low-volume | 62/101 (61 %) | 1.0a | 1.0a |
| Medium-volume | 393/747 (53 %) | 0.70 (0.46–1.07) | 1.13 (0.68–1.87) |
| High-volume | 700/947 (72 %) | 1.61 (1.05–2.46) | 2.58 (1.56–4.26) |
| DNT < 60 min | |||
| Low-volume | 75/101 (74 %) | 1.0a | 1.0a |
| Medium-volume | 573/747 (77 %) | 1.14 (0.71–1.84) | 1.72 (1.01–2.94) |
| High-volume | 819/974 (84 %) | 1.83 (1.14–2.95) | 2.74 (1.61–4.69) |
| ONT < 150 min | |||
| Low-volume | 71/101 (70 %) | 1.0a | 1.0a |
| Medium-volume | 468/700 (67 %) | 0.85 (0.54–1.34) | 0.92 (0.54–1.58) |
| High-volume | 653/956 (69 %) | 0.91 (0.58–1.43) | 1.06 (0.62–1.80) |
| ONT < 120 min | |||
| Low-volume | 59/101 (58 %) | 1.0a | 1.0a |
| Medium-volume | 348/700 (50 %) | 0.70 (0.46–1.07) | 0.66 (0.40–1.10) |
| High-volume | 511/956 (54 %) | 0.82 (0.54–1.24) | 0.81 (0.49–1.35) |
| Symptomatic ICH | |||
| Low-volume | 10/101 (10 %) | 1.0a | 1.0a |
| Medium-volume | 43/745 (6 %) | 0.56 (0.27–1.15) | 0.45 (0.19–1.07) |
| High-volume | 42/973 (4 %) | 0.41 (0.20–0.85) | 0.39 (0.16–0.92) |
| In-hospital mortality | |||
| Low-volume | 17/101 (17 %) | 1.0a | 1.0a |
| Medium-volume | 60/747 (8 %) | 0.43 (0.24–0.77) | 0.36 (0.16–0.82) |
| High-volume | 87/973 (9 %) | 0.49 (0.28–0.85) | 0.45 (0.21–1.01) |
Unadjusted and adjusted odds ratios (OR) for different cut-offs of the DNT and ONT are given
CI confidence interval, DNT door-to-needle time, ONT onset-to-needle time
aReference category